 U.S. health officials have approved a new Alzheimer's drug that can modestly slow the disease. It's only the second drug that's been convincingly shown to slow the memory-destroying condition. The Food and Drug Administration approved Eli Lilly's medication Tuesday for patients with early or mild cases of dementia caused by Alzheimer's. On Wall Street, they're up by 162 points. More at townhall.com.